Overview
This study is planned to examine the effect of video-assisted laughter yoga on pain and menstrual symptoms among students studying at a university in Türkiye. Data will be collected at the Faculty of Health Sciences, Konya Karatay University, between November 2025 and April 2026. The study population will consist of students aged 18 to 24 years studying at the Faculty of Health Sciences during the specified period. The sample size was calculated using the G Power computer program. Using a power analysis at the α=0.05 level, the effect size was calculated as 150, 153 (d=0.8), and the working power was calculated as 90%, indicating that at least 68 students should be included in the sample. Students meeting the research criteria and agreeing to participate in the study will be randomly assigned to an experimental group and a control group. The socio-demographic data of the students in the Faculty of Health Sciences, the Visual Analog Scale to assess students' pain, and the Menstrual Symptom Scale to measure menstrual symptoms, prepared by the researcher in accordance with the literature, will be used.
Description
Research data will be collected face-to-face by the researcher. The study will be conducted with students who meet the inclusion criteria (being a student in the Faculty of Health Sciences, being willing to participate in the research, and being open to communication and collaboration). Pre-test assessment tools will be administered to the participating students. Following this, Laughter Yoga practice will be conducted. A total of 24 sessions will be implemented. Final post-test data will be administered after the last session.
Eligibility
Inclusion Criteria:
- Students with regular menstrual periods (lasting 3-8 days, with a menstrual cycle range of 21-35 days)
- Students with dysmenorrhea pain intensity of 45 mm or more according to the Visual Analog Scale (VAS).
Exclusion Criteria:
- Students diagnosed with secondary dysmenorrhea (endometriosis, ovarian cyst/tumor, pelvic infectious disease, myoma, uterine polyps, uterine adhesions, infection, etc.),
- those using oral contraceptives,
- those with compromised tissue integrity in the abdominal area,
- those with any chronic or mental illness.


